Arcus Biosciences Inc (RCUS)
17.56
+0.46
(+2.66%)
USD |
NYSE |
May 15, 16:00
17.56
0.00 (0.00%)
After-Hours: 16:14
Arcus Biosciences Total Assets (Quarterly): 1.293B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.293B |
| December 31, 2023 | 1.095B |
| September 30, 2023 | 1.191B |
| June 30, 2023 | 1.22B |
| March 31, 2023 | 1.254B |
| December 31, 2022 | 1.345B |
| September 30, 2022 | 1.394B |
| June 30, 2022 | 1.477B |
| March 31, 2022 | 1.543B |
| December 31, 2021 | 1.592B |
| September 30, 2021 | 839.29M |
| June 30, 2021 | 898.77M |
| March 31, 2021 | 935.12M |
| Date | Value |
|---|---|
| December 31, 2020 | 772.29M |
| September 30, 2020 | 811.08M |
| June 30, 2020 | 481.39M |
| March 31, 2020 | 176.14M |
| December 31, 2019 | 203.11M |
| September 30, 2019 | 216.96M |
| June 30, 2019 | 238.97M |
| March 31, 2019 | 258.53M |
| December 31, 2018 | 274.92M |
| September 30, 2018 | 286.72M |
| June 30, 2018 | 293.86M |
| March 31, 2018 | 305.40M |
| December 31, 2017 | 190.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
176.14M
Minimum
Mar 2020
1.592B
Maximum
Dec 2021
948.86M
Average
1.015B
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 56.29B |
| Catalyst Pharmaceuticals Inc | 646.68M |
| Integra Lifesciences Holdings Corp | 4.078B |
| Vertex Pharmaceuticals Inc | 23.92B |
| Adverum Biotechnologies Inc | 267.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 586.00M |
| Shareholders Equity (Quarterly) | 707.00M |
| Current Ratio | 5.216 |